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Introduction
1H-NMR spectroscopy has successfully been applied to 
the field of inborn errors of metabolism (IEM). However, 
body fluid NMR spectra lead to a wealth of data and it 
can be a daunting task to find the relevant information.
Aim .
To demonstrate the use of chemometric methods in 
NMR-based urine analyses to diagnose patients with 
IEM. Alkaptonuria (ALK) and methylmalonic aciduria 
(MMA) will be used as examples.
Materials and methods
Sample collection: Urine samples were obtained from 58 
healthy volunteers, 5 patients with ALK and 6 patients 
with MMA.
NMR spectroscopy: Urine samples were measured at 
500MHz. 1D 1H-NMR spectra were acquired as 128 
transients in 32K data points with a spectral width of 
6002 Hz.
CHEMOMETRY: Spectra have been bucketed with a 
bucket size of 0.02 ppm, and scaled the creatinine peak 
at 3.13 ppm (Figure 1.) The region 4.6–4.9 ppm, which 
contains the residual water peak, was removed prior to 
statistical analysis.
PLS-DA
This  method is supervised, i.e. the class membership of the samples 
is included in the calculation. PLS-DA can be used to make models 
that discriminate between classes (diseased versus healthy). 
Figure 4 shows PLS-DA scores of the three groups (log-
scaled). Already the first component shows perfect 
separation between the three groups
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Results
The urine NMR data were classified using Principal 
Component Analysis (PCA; Figure 3) and Partial Least 
Square Discriminant Analysis (PLS-DA; Figure 4).
PCA
PCA is a unsupervised since it does not take into account class labels. 
PCA can quickly provide insightful graphical overviews of the data, 
making it possible to identify gross outliers, group structure and 
relations between samples and variables.
Figure 3a shows the result of the PCA analysis of urine 
samples of healthy controls and the patients with MMA 
and ALK. The first and third PCs shown clearly 
discriminate between the three classes. The loading 
plots (Figure 3b) give an indication which variables are 
involved. On the horizontal axis, two variables jump 
out: ppm values 1.37 and 3.53. Both are signals from 
methylmalonic acid, the metabolite associated with 
MMA. On PC 3, we can clearly distinguish ppm values 
3.63 and 6.75, coming from homogentisic acid, the 
metabolite associated with ALK.
Conclusion
Using PCA and PLS-DA 
analyses, discrimination of 
MMA and ALK urine samples 
from normal urine samples 
was possible by the different 
models produced.
Chemometric techniques can 
assist in the interpretation of 
complex urine NMR data and 
may be useful in the rapid 
screening of patients with IEM. 
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Figure 1: Randomly chosen urine NMR spectrum from a healthy volunteer. 
The spectrum is divided into equally sized regions (0.02 ppm).  
Results
1H-NMR spectra of urine may contain more than 
hundred resonances, deriving from endogenous or 
exogenous metabolites. Figure 2 shows examples of 
urine NMR spectra of a healthy volunteer (2A and B), a 
patient with ALK (2C) and a patient with MMA (2D).
Figure 3: PCA analysis of urine. Scores (a) and loadings (b) plots
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Figure 2:Urine 1H-NMR spectra of a healthy volunteer (2A and B), a patient with ALK 
(2C) and a patient with MMA (2D).
Figure 4: PLSDA scores 
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